“We are delighted to have Novo Nordisk join as a member of Vivli, particularly given it’s innovative and life-changing drugs,” said Rebecca Li, Vivli CEO. “We look forward to working with the team at Novo Nordisk to share their data to meet their data sharing commitments.”

Novo Nordisk is committed to sharing information about clinical studies and their results.

For more information about the conditions for accessing Novo Nordisk data, please visit their member page. For additional information about Membership in Vivli, learn more here.